These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 8137220

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. M-VEC (methotrexate, vinblastine, epirubicin, and cisplatin) with granulocyte colony-stimulating factor for the treatment of urothelial cancer: an effective and safe chemotherapy regimen.
    Igawa M, Kadena H, Ueda M, Usui T.
    Cancer Chemother Pharmacol; 1994; 35 Suppl():S1-4. PubMed ID: 7527732
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
    Edelman MJ, Meyers FJ, Houston J, Lauder I.
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
    [Abstract] [Full Text] [Related]

  • 5. Chemotherapy with methotrexate, vinblastine, epirubicin and carboplatin (Carbo-MVE) in transitional cell urothelial cancer. A Hellenic Co-Operative Oncology Group study.
    Skarlos DV, Aravantinos G, Linardou E, Kostakopoulos CA, Kastriotis I, Christodoulou C, Picramenos D, Giannakakis T, Dimopoulos K, Fountzilas G.
    Eur Urol; 1997 Oct; 31(4):420-7. PubMed ID: 9187901
    [Abstract] [Full Text] [Related]

  • 6. A carboplatin-based regimen for the treatment of patients with advanced transitional cell carcinoma of the urothelium.
    Small EJ, Fippin LJ, Ernest ML, Carroll PR.
    Cancer; 1996 Oct 15; 78(8):1775-80. PubMed ID: 8859191
    [Abstract] [Full Text] [Related]

  • 7. Methotrexate-paclitaxel-epirubicin-carboplatin (M-TEC) combination chemotherapy in patients with advanced bladder cancer: an open label phase II study.
    Tsavaris N, Kosmas C, Skopelitis H, Dimitrakopoulos A, Kopterides P, Bougas D, Stravodimos K, Mitropoulos D, Alamanis C, Giannopoulos A.
    J Chemother; 2005 Aug 15; 17(4):441-8. PubMed ID: 16167525
    [Abstract] [Full Text] [Related]

  • 8. A pharmacologically guided phase I study of carboplatin in combination with methotrexate and vinblastine in advanced urothelial cancer.
    Chatelut E, Chevreau C, Brunner V, Martinez M, Houin G, Bugat R, Canal P.
    Cancer Chemother Pharmacol; 1995 Aug 15; 35(5):391-6. PubMed ID: 7850920
    [Abstract] [Full Text] [Related]

  • 9. Cisplatin, ifosfamide, methotrexate and vinblastine combination chemotherapy for metastatic urothelial cancer.
    Kyriakakis Z, Dimopoulos MA, Kostakopoulos A, Karayiannis A, Sofras F, Zervas A, Giannopoulos A, Dimopoulos C.
    J Urol; 1997 Aug 15; 158(2):408-11. PubMed ID: 9224313
    [Abstract] [Full Text] [Related]

  • 10. Treatment of advanced urothelial carcinoma with M-VECA (methotrexate, vinblastine, epirubicin and carboplatin).
    Lorusso V, Pagliarulo A, Selvaggi FP, Durini E, Riccardi F, Comella P, Fiorillo C, De Lena M.
    J Chemother; 1996 Apr 15; 8(2):154-8. PubMed ID: 8708748
    [Abstract] [Full Text] [Related]

  • 11. Feasibility trial of methotrexate-paclitaxel as a second line therapy in advanced urothelial cancer.
    Bellmunt J, Cos J, Clèries R, Pérez M, Ribas A, Eres N, Murio JE, Margarit C, Baselga J.
    Cancer Invest; 2002 Apr 15; 20(5-6):673-85. PubMed ID: 12197223
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Randomized phase II/III trial assessing gemcitabine/ carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer "unfit" for cisplatin-based chemotherapy: phase II--results of EORTC study 30986.
    De Santis M, Bellmunt J, Mead G, Kerst JM, Leahy M, Maroto P, Skoneczna I, Marreaud S, de Wit R, Sylvester R.
    J Clin Oncol; 2009 Nov 20; 27(33):5634-9. PubMed ID: 19786668
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinoma.
    Bellmunt J, Ribas A, Eres N, Albanell J, Almanza C, Bermejo B, Solé LA, Baselga J.
    Cancer; 1997 Nov 15; 80(10):1966-72. PubMed ID: 9366300
    [Abstract] [Full Text] [Related]

  • 18. Results of adjuvant chemotherapy for invasive urothelial cancer with lymph-node metastasis.
    Kobayashi H, Obata K.
    Cancer Chemother Pharmacol; 1994 Nov 15; 35 Suppl():S14-7. PubMed ID: 7994781
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Carboplatin, methotrexate and vinblastin (Carbo-MV) for advanced urothelial cancer. A phase II trial.
    Klocker J, Pont J, Schumer J, Prüger J, Kienzer H.
    Am J Clin Oncol; 1991 Aug 15; 14(4):328-30. PubMed ID: 1862764
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.